INSPECS Group (SPEC) Competitors GBX 57 -1.50 (-2.56%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades SPEC vs. TSTL, BVC, AKR, CNSL, ODX, CTEC, AMS, VRP, BVXP, and INSShould you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include Tristel (TSTL), BATM Advanced Communications (BVC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Verona Pharma plc (VRP.L) (VRP), Bioventix (BVXP), and Instem (INS). These companies are all part of the "medical" sector. INSPECS Group vs. Tristel BATM Advanced Communications Akers Biosciences Cambridge Nutritional Sciences Omega Diagnostics Group ConvaTec Group Advanced Medical Solutions Group Verona Pharma plc (VRP.L) Bioventix Instem INSPECS Group (LON:SPEC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, community ranking, profitability and institutional ownership. Is SPEC or TSTL a better dividend stock? INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.8%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.0%. INSPECS Group pays out -32.6% of its earnings in the form of a dividend. Tristel pays out 10,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Do insiders and institutionals have more ownership in SPEC or TSTL? 67.8% of INSPECS Group shares are held by institutional investors. Comparatively, 50.4% of Tristel shares are held by institutional investors. 25.6% of INSPECS Group shares are held by insiders. Comparatively, 4.9% of Tristel shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, SPEC or TSTL? Tristel has lower revenue, but higher earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINSPECS Group£195.14M0.30-£4.11M-£3.07-18.57Tristel£39.49M5.31£6.04M£0.133,384.62 Does the MarketBeat Community favor SPEC or TSTL? Tristel received 143 more outperform votes than INSPECS Group when rated by MarketBeat users. However, 100.00% of users gave INSPECS Group an outperform vote while only 57.36% of users gave Tristel an outperform vote. CompanyUnderperformOutperformINSPECS GroupOutperform Votes5100.00% Underperform VotesNo VotesTristelOutperform Votes14857.36% Underperform Votes11042.64% Does the media favor SPEC or TSTL? In the previous week, Tristel had 2 more articles in the media than INSPECS Group. MarketBeat recorded 2 mentions for Tristel and 0 mentions for INSPECS Group. Tristel's average media sentiment score of 0.50 beat INSPECS Group's score of 0.00 indicating that Tristel is being referred to more favorably in the news media. Company Overall Sentiment INSPECS Group Neutral Tristel Neutral Which has more risk and volatility, SPEC or TSTL? INSPECS Group has a beta of 2.22, meaning that its stock price is 122% more volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Is SPEC or TSTL more profitable? Tristel has a net margin of 15.29% compared to INSPECS Group's net margin of -2.11%. Tristel's return on equity of 20.35% beat INSPECS Group's return on equity.Company Net Margins Return on Equity Return on Assets INSPECS Group-2.11% -3.95% 0.45% Tristel 15.29%20.35%9.89% SummaryTristel beats INSPECS Group on 11 of the 17 factors compared between the two stocks. Ad DTILet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now Get INSPECS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPEC vs. The Competition Export to ExcelMetricINSPECS GroupMedical Instruments & Supplies IndustryMedical SectorLON ExchangeMarket Cap£57.95M£2.89B£5.07B£1.59BDividend Yield2.00%2.01%5.09%6.99%P/E Ratio-18.57343.87101.941,725.19Price / Sales0.30169.361,197.29243,477.65Price / Cash1.63146.5440.9627.29Price / Book0.573.116.332.93Net Income-£4.11M£91.96M£119.64M£156.92M7 Day Performance-7.32%-0.14%-5.13%-0.62%1 Month Performance3.17%-0.72%-2.72%3.25%1 Year Performance-32.94%4.66%31.06%121.00% INSPECS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPECINSPECS GroupN/AGBX 57-2.6%N/A-32.9%£57.95M£195.14M-18.571,673TSTLTristelN/AGBX 452.50+1.1%N/A+5.4%£215.62M£39.49M3,480.77208BVCBATM Advanced CommunicationsN/AGBX 19+2.8%N/A-8.1%£82.88M£122.70M2,800.00980Gap UpAKRAkers BiosciencesN/AGBX 57.50flatN/AN/A£21.64M£2.32M-0.44120CNSLCambridge Nutritional SciencesN/AGBX 3.20flatN/AN/A£7.61M£9.77M-362.103,200ODXOmega Diagnostics GroupN/AGBX 2.20flatN/AN/A£5.23M£7.55M-220.0091Gap DownCTECConvaTec Group2.3807 of 5 starsN/AN/A+9.8%£5.26B£2.20B4,406.6710,000News CoverageAMSAdvanced Medical Solutions Group2.3852 of 5 starsGBX 215.50-4.2%N/A-4.5%£462.36M£131.11M4,310.0010Insider SellingNews CoverageGap UpVRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/A+0.0%£228MN/A-1.6822Gap UpBVXPBioventixN/AGBX 3,900-1.3%N/A+3.4%£203.58M£13.60M2,392.6412News CoverageHigh Trading VolumeINSInstemN/AN/AN/A+0.0%£199.62M£61.63M5,928.57500 Related Companies and Tools Related Companies TSTL Alternatives BVC Alternatives AKR Alternatives CNSL Alternatives ODX Alternatives CTEC Alternatives AMS Alternatives VRP Alternatives BVXP Alternatives INS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SPEC) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INSPECS Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share INSPECS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
